Clinical Trial Update: Adjuvant Systemic Treatment for (ER)-Positive HER2-negative Breast Carcinoma in Women Over 70 According to Genomic Grade (GG): Chemotherapy + Endocrine Treatment Versus Endocrine Treatment [Phase 3]

View source ↗

Summary

This Phase 3 trial compares chemotherapy plus endocrine therapy versus endocrine therapy alone for ER-positive, HER2-negative breast cancer in women over 70, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: UNICANCER | Conditions: Breast Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING